Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
Mucormycosis is a life-threatening fungal infection usually seen in patients who are immunocompromised; however, to date, it has been rarely described in patients with COVID-19, although more recently, reports from India have described an increased incidence of these infections. This report describ...
Saved in:
| Main Authors: | Raham Rahgoshai, Peter Goldberg, Rayhaneh Rahgoshai, Shadi Zain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2022-10-01
|
| Series: | European Medical Journal |
| Online Access: | https://www.emjreviews.com/respiratory/article/cutaneous-mucormycosis-co-infection-in-a-patient-with-covid-19/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Double Jeopardy: Cutaneous Mucormycosis in a Renal Transplant Patient Post-COVID-19
by: Radha Vijayaraghavan, et al.
Published: (2025-04-01) -
Non-COVID-19 Cutaneous Mucormycosis from a Plastic Surgical Perspective
by: Vimalendu Brajesh, et al.
Published: (2023-08-01) -
Mucormycosis: An Emerging Fungal Infection in the COVID-19 Pandemic
by: Parisa Saberi-Hasanabadi1, 2, et al.
Published: (2024-06-01) -
Cutaneous mucormycosis: Unveiling rare manifestations
by: Jyoti Jindal, et al.
Published: (2025-06-01) -
Cutaneous Mucormycosis in a Patient With Cirrhosis: A Case Report
by: Haley Belt MD, et al.
Published: (2025-07-01)